Visus Therapeutics
Founded Year
2019Stage
Series A - II | AliveTotal Raised
$56MLast Raised
$20M | 2 yrs agoAbout Visus Therapeutics
Visus Therapeutics is a clinical-stage company that provides pharmaceutical products. It is in pursuit of developing the world’s first presbyopia-correcting eye drop. The company was founded in 2019 and is based in Seattle, Washington.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Visus Therapeutics Patents
Visus Therapeutics has filed 4 patents.
The 3 most popular patent topics include:
- Ophthalmology
- Acetylcholinesterase inhibitors
- Combination drugs
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
6/10/2020 | Acetylcholinesterase inhibitors, Combination drugs, Ophthalmology, Organophosphate insecticides, Corrective lenses | Application |
Application Date | 6/10/2020 |
|---|---|
Grant Date | |
Title | |
Related Topics | Acetylcholinesterase inhibitors, Combination drugs, Ophthalmology, Organophosphate insecticides, Corrective lenses |
Status | Application |
Latest Visus Therapeutics News
Sep 8, 2023
SEATTLE & IRVINE, Calif.--(BUSINESS WIRE)--Visus Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing multi-targeted ophthalmic therapies for indications in the front and back of the eye, today announced that Ben Bergo, co-founder and chief executive officer, will present at the Baird 2023 Global Healthcare Conference on September 12th, 2023, at the InterContinental New York Barclay hotel. The presentation is scheduled for 8:30 AM Eastern Time on Tuesday, Septembe
Visus Therapeutics Frequently Asked Questions (FAQ)
When was Visus Therapeutics founded?
Visus Therapeutics was founded in 2019.
Where is Visus Therapeutics's headquarters?
Visus Therapeutics's headquarters is located at 2 Nickerson St., Seattle.
What is Visus Therapeutics's latest funding round?
Visus Therapeutics's latest funding round is Series A - II.
How much did Visus Therapeutics raise?
Visus Therapeutics raised a total of $56M.
Who are the investors of Visus Therapeutics?
Investors of Visus Therapeutics include Johnson & Johnson Innovation, EQT Life Sciences, Sage Partners, RTW Investments and Wille AG.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
